Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen Pushes Ahead With "Son of Dmab" for Treating Bones
Amgen Pushes Ahead With "Son of Dmab" for Treating Bones
Amgen Pushes Ahead With "Son of Dmab" for Treating Bones
Submitted by
admin
on February 9, 2011 - 1:14pm
Source:
Motley Fool
News Tags:
Amgen
AMG785
denosumab
osteoporosis
Headline:
Amgen Pushes Ahead With "Son of Dmab" for Treating Bones
Do Not Allow Advertisers to Use My Personal information
